Commitments and Contingencies - Additional Information (Details) - USD ($)	1 Months Ended	12 Months Ended
Mar. 31, 2020	Dec. 31, 2021
Maximum \| Research and Development Service Agreement
Commitments And Contingencies Disclosure [Line Items]
Potential payment for milestone		$ 1,750,000
Termination payments		500,000
Preclinical Studies and Clinical Trials \| MDACC
Commitments And Contingencies Disclosure [Line Items]
Contractual obligation	$ 10,000,000.0
Contractual obligation period	5 years
Contractual obligation paid		$ 3,000,000.0

All amounts that, per contract, are due to the servicer in exchange for servicing the financial asset and would no longer be received by a servicer if the beneficial owners of the serviced assets (or their trustees or agents) were to exercise their actual or potential authority under the contract to shift the servicing to another servicer. Depending on the servicing contract, those fees may include some or all of the difference between the interest rate collected on the asset being serviced and the rate to be paid to the beneficial owners of the asset.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 50
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=125521744&loc=d3e122596-111746

Name:	us-gaap_ContractuallySpecifiedServicingFeesAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration